Teleflex Incorporated $TFX Shares Acquired by LSV Asset Management

LSV Asset Management increased its holdings in Teleflex Incorporated (NYSE:TFX) by 685.2% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 63,600 shares of the medical technology company’s stock after acquiring an additional 55,500 shares during the quarter. LSV Asset Management owned approximately 0.14% of Teleflex worth $7,762,000 at the end of the most recent quarter.

Other institutional investors have also modified their holdings of the company. Banque Cantonale Vaudoise grew its position in Teleflex by 82.5% in the fourth quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock valued at $31,000 after acquiring an additional 113 shares in the last quarter. Fifth Third Bancorp grew its position in Teleflex by 7.8% in the third quarter. Fifth Third Bancorp now owns 2,083 shares of the medical technology company’s stock valued at $255,000 after acquiring an additional 151 shares in the last quarter. Oregon Public Employees Retirement Fund grew its position in Teleflex by 1.7% in the fourth quarter. Oregon Public Employees Retirement Fund now owns 10,114 shares of the medical technology company’s stock valued at $1,234,000 after acquiring an additional 167 shares in the last quarter. Osaic Holdings Inc. grew its position in Teleflex by 17.5% in the second quarter. Osaic Holdings Inc. now owns 1,247 shares of the medical technology company’s stock valued at $148,000 after acquiring an additional 186 shares in the last quarter. Finally, Hantz Financial Services Inc. grew its position in Teleflex by 248.8% in the third quarter. Hantz Financial Services Inc. now owns 279 shares of the medical technology company’s stock valued at $34,000 after acquiring an additional 199 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several brokerages have issued reports on TFX. Royal Bank Of Canada raised shares of Teleflex from a “sector perform” rating to an “outperform” rating and increased their price objective for the company from $135.00 to $155.00 in a research report on Friday, May 8th. Weiss Ratings reiterated a “sell (d)” rating on shares of Teleflex in a research note on Friday, March 27th. Truist Financial reiterated a “hold” rating and set a $143.00 target price (up from $135.00) on shares of Teleflex in a research note on Monday, May 11th. Raymond James Financial reiterated an “outperform” rating and set a $150.00 target price on shares of Teleflex in a research note on Friday, May 8th. Finally, Needham & Company LLC increased their target price on Teleflex from $138.00 to $147.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Three equities research analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Teleflex presently has a consensus rating of “Hold” and an average price target of $144.00.

Teleflex Stock Performance

Teleflex stock opened at $132.02 on Wednesday. The stock has a market cap of $5.84 billion, a P/E ratio of -5.79, a price-to-earnings-growth ratio of 0.99 and a beta of 0.82. The company has a current ratio of 2.55, a quick ratio of 2.03 and a debt-to-equity ratio of 0.82. The stock has a 50 day moving average of $123.62 and a 200-day moving average of $116.99. Teleflex Incorporated has a 52 week low of $100.18 and a 52 week high of $139.67.

Teleflex (NYSE:TFX) last released its earnings results on Thursday, May 7th. The medical technology company reported $1.39 EPS for the quarter, beating the consensus estimate of $1.21 by $0.18. The company had revenue of $548.30 million during the quarter, compared to analysts’ expectations of $536.91 million. Teleflex had a positive return on equity of 13.29% and a negative net margin of 35.88%.The business’s revenue was up 32.3% on a year-over-year basis. During the same period in the prior year, the business posted $1.44 EPS. Teleflex has set its FY 2026 guidance at 6.250-6.550 EPS. On average, analysts expect that Teleflex Incorporated will post 6.7 EPS for the current fiscal year.

Teleflex Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 30th. Investors of record on Monday, May 25th will be paid a dividend of $0.34 per share. The ex-dividend date is Friday, May 22nd. This represents a $1.36 annualized dividend and a yield of 1.0%. Teleflex’s dividend payout ratio (DPR) is -5.96%.

About Teleflex

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.